Johnson & Johnson Johnson & Johnson (NYSE: JNJ) COVID-19 Vaccine Gets Emergency Use Authorization in India Johnson & Johnson (NYSE: JNJ) disclosed that it has earned the emergency use authorization for its single-dose COVID-19 vaccine. The firm disclosed that it has applied for emergency use authorization for its COVID-19 vaccine.
